NEW YORK (GenomeWeb) – Provista Diagnostics said today that its Scottsdale Ariz.-based CLIA-certified laboratory has received accreditation from the College of American Pathologists.

Provista is a molecular diagnostics firm focused on blood-based proteomic tests for disease including breast and ovarian cancer. Additionally, the company offers diagnostic development services to outside firms through its CLIA facility.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.